Pharmacotherapy of depression in older adults

Geriatrics and Aging

Volumn 8, Issue 8, 2005, Pages 20-27

  Ravindran, Lakshmi ^a   Conn, David ^b   Ravindran, Arun ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antidepressants; Augmentation; Depressive disorders; Nonresponse; Older adult

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; AMITRIPTYLINE; ANTIHYPERTENSIVE AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CYTOCHROME P450; DESIPRAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LAMOTRIGINE; LITHIUM; LORAZEPAM; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; STEROID; THYROID HORMONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; UNINDEXED DRUG; VENLAFAXINE;

AGED; AGITATION; ANTICHOLINERGIC EFFECT; ARTICLE; BODY WEIGHT DISORDER; CARDIOVASCULAR DISEASE; COMORBIDITY; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DYSTHYMIA; ELECTROCONVULSIVE THERAPY; FOOD DRUG INTERACTION; FREQUENCY ANALYSIS; GASTROINTESTINAL SYMPTOM; GERIATRIC CARE; HEART BLOCK; HUMAN; HYPERTENSIVE CRISIS; INSOMNIA; MAINTENANCE THERAPY; MAJOR DEPRESSION; MENTAL STRESS; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REMISSION; SEDATION; SEROTONINERGIC SYSTEM; SEXUAL DYSFUNCTION; SINUS TACHYCARDIA; TREATMENT PLANNING;

EID: 25844489489     PISSN: 14888408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Koenig HG, Blazer DG. Epidemiology of geriatric affective disorders. Clin Geriatr Med 1992;8:235-51.
2. Luber MP, Hollenberg JP, Williams-Russo P, et al. Depression and service utilization in elderly primary care patients. Am J Geriatr Psychiatry 2001;9:169-76.
3. Alexopoulos, GS. Late-life mood disorders. In: Sadavoy J, Jarvik LF, Grossberg GT, et al., editors. Comprehensive textbook on geriatric psychiatry (3rd ed.). New York: W. W. Norton & Company, Inc., 2004: 609-53.
4. Kroenke K, Spitzer RL, Williams JB, et al. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994;3:774-9.
5. Alexopoulos GS, Katz IR, Reynolds CF, et al. Pharmacotherapy of depression in older patients: a summary of the expert consensus guidelines. J Psychiatr Practice 2001;361-76.
6. Flint AJ. Choosing appropriate antidepressant therapy in the elderly: a risk-benefit assessment of available agents. Drugs Aging 1998;13:269-80.
7. Reynolds CF, Frank E, Dew MA, et al. Discrimination of recovery in the treatment of elderly patients with recurrent major depression: limits of prediction. Depression 1995;2:218-22.
8. Frank E. Long-term recurrences in elderly patients. In: Diagnosis and treatment of depression in late life: results of the NIH Consensus Development Conference. Washington, DC: American Psyciatric Press; 1994: 317-29.
9. Reynolds CF, Perel JM, Frank E, et al. Three-year outcomes of maintenance nortriptyline treatment in late-life depression: a study of two fixed plasma levels. Am J Psychiatry 1999;156:1177-81.
10. Meyers BS, Young RC. Psychopharmacology. In: Sadavoy J, Jarvik LF, Grossberg GT, et al., editors. Comprehensive textbook on Geriatric psychiatry (3rd edition). New York: W. W. Norton & Company, Inc., 2004:903-91.
11. Flint AJ, Rifat SL. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. J Clin Psychopharmacol 1994;14:353-56.
12. Reynolds CF, Frank E, Perel JM, et al. High relapse rates after discontinuation of adjunctive medication for elderly patients with recurrent major depression. Am J Psychiatry 1996;1418-22.
13. Glassman AH, Bigger JT Jr. Cardiovascular effects of therapeutic doses of the tricyclic antidepressants: a review. Arch Gen Psychiatry 1981;38:815-20.
14. Flint AJ, Rifat SL. The effect of sequential antidepressant treatment on geriatric depression. J Affect Disord 1996;36:95-105.
15. Bocksberger JP, Gachoud JP, Richard J, et al. Comparison of the efficacy of moclobemide and fluvoxamine in elderly patients with a severe depressive episode. Eur Psychiatry 1993;8:319-24.
16. Sackheim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001;285:1299-307.
17. Williams JW, Barrett J, Oxman T, et al. Treatment of dystymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA 2000;284:1519-26.
18. Reynolds, CF, Alexopoulos GS, Katz IR, et al. Chronic depression in the elderly: approaches for prevention. Drugs Aging 2001;18:507-14.
19. Lenze EJ, Mulsant BH, Shear MK, et al. Anxiety symptoms in elderly patients with depression-what is the best approach to treatment? Drugs Aging 2001;19:753-60.
20. Morrow EM, Falk WE. Diagnosis and pharmacotherapy of anxiety in older patients. Geriatrics Aging 2005;8:37-41.
21. Birrer RB, Vemuri SP. Depression in later fife: a diagnostic and therapeutic challenge. Am Fam Physician 2004;69:2375-82.
22. Barkin RL, Fawcett J. The management challenges of chronic pain: the role of antidepressants. Am J Ther 2000;7:31-47.
23. Katona CL, Hunter BN, Bray J. A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia. In J Geriatr Psychiatry 1998;13:100-8.